ACE2 and COVID-19: In light of the COVID-19 pandemic, interest in the function of the RAS in the context of ARDS has grown, as ACE2 serves as the primary cell entry receptor for SARS-CoV-2 (Walls et al., 2020; Yan et al., 2020; Zhang et al., 2020).